| Outgoing Relation(s) |
| EC 3.1.1.3 (triacylglycerol lipase) inhibitor (CHEBI:65001) is a EC 3.1.1.* (carboxylic ester hydrolase) inhibitor (CHEBI:76773) |
| Incoming Relation(s) |
| 3-O-trans-p-coumaroyl actinidic acid (CHEBI:65661) has role EC 3.1.1.3 (triacylglycerol lipase) inhibitor (CHEBI:65001) |
| 7-phloroeckol (CHEBI:65790) has role EC 3.1.1.3 (triacylglycerol lipase) inhibitor (CHEBI:65001) |
| atglistatin (CHEBI:228145) has role EC 3.1.1.3 (triacylglycerol lipase) inhibitor (CHEBI:65001) |
| benzaldehyde (CHEBI:17169) has role EC 3.1.1.3 (triacylglycerol lipase) inhibitor (CHEBI:65001) |
| benzoic acid (CHEBI:30746) has role EC 3.1.1.3 (triacylglycerol lipase) inhibitor (CHEBI:65001) |
| galangin (CHEBI:5262) has role EC 3.1.1.3 (triacylglycerol lipase) inhibitor (CHEBI:65001) |
| gypsosaponin A (CHEBI:65992) has role EC 3.1.1.3 (triacylglycerol lipase) inhibitor (CHEBI:65001) |
| gypsosaponin B (CHEBI:65993) has role EC 3.1.1.3 (triacylglycerol lipase) inhibitor (CHEBI:65001) |
| gypsosaponin C (CHEBI:65994) has role EC 3.1.1.3 (triacylglycerol lipase) inhibitor (CHEBI:65001) |
| litseaefoloside C (CHEBI:66582) has role EC 3.1.1.3 (triacylglycerol lipase) inhibitor (CHEBI:65001) |
| orlistat (CHEBI:94686) has role EC 3.1.1.3 (triacylglycerol lipase) inhibitor (CHEBI:65001) |
| sodium benzoate (CHEBI:113455) has role EC 3.1.1.3 (triacylglycerol lipase) inhibitor (CHEBI:65001) |
